Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 270
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))

Recruiting
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +95 more
Mar 31, 2022

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Eversense® CGM system)

Active, not recruiting
  • Diabetes Mellitus
  • +2 more
  • Eversense® CGM system
  • Newport Beach, California
  • +16 more
Mar 31, 2022

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Sacramento, California
  • +122 more
Mar 21, 2022

Diabetes, Type 2 Trial in United States (Gan & Lee Insulin Glargine Injection, Lantus®)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Gan & Lee Insulin Glargine Injection
  • Lantus®
  • Birmingham, Alabama
  • +56 more
Mar 23, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin Icodec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin Icodec
  • Buena Park, California
  • +71 more
Mar 29, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Insulin glargine, insulin aspart)

Recruiting
  • Diabetes Mellitus, Type 2
  • La Jolla, California
  • +100 more
Mar 24, 2022

Diabetes, Type 2 Trial in Worldwide (BI 456906, Placebo, Semaglutide)

Completed
  • Diabetes Mellitus, Type 2
  • BI 456906
  • +2 more
  • Huntington Park, California
  • +79 more
Mar 22, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +128 more
Feb 14, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Prediabetes and Type 2 Diabetes Data Collection Study

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Pre-diabetes
  • G6
  • Lemon Grove, California
  • +4 more
Oct 4, 2021

Diabetes, Type 2 Trial in Germany, United States (LY3502970, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Hialeah, Florida
  • +5 more
Jul 26, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +184 more
Jul 1, 2021

Diabetes, Type 2 Trial in Worldwide (LY2944876, Exenatide extended-release, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +50 more
May 25, 2021

A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
    • San Antonio, Texas
      (unnamed)
    May 12, 2021

    Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Continuous Glucose Monitoring System)

    Completed
    • Diabetes Mellitus
    • +2 more
    • Continuous Glucose Monitoring System
    • Concord, California
    • +7 more
    Mar 30, 2021

    Diabetes, Type 2 Trial in Canada, United States (CGM, SMBG)

    Completed
    • Diabetes Mellitus, Type 2
    • CGM
    • SMBG
    • Huntington Beach, California
    • +9 more
    Mar 18, 2021

    Diabetes, Type 2, Insulin Resistance Trial in San Antonio (HydraSolve T2D™)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Insulin Resistance
    • HydraSolve T2D™
    • San Antonio, Texas
      University of Texas Health Science Center at San Antonio
    Mar 16, 2021

    Erectile Dysfunction, Diabetes, Type 2 Trial in Canada, United States (sildenafil, )

    Completed
    • Erectile Dysfunction
    • Diabetes Mellitus, Type 2
    • Huntsville, Alabama
    • +28 more
    Jan 28, 2021

    NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

    Completed
    Has Results
    • NAFLD
    • +3 more
    • Placebo
    • +3 more
    • Chandler, Arizona
    • +41 more
    Jan 28, 2021

    Diabetes, Type 2 Trial in United States (LY3437943, Dulaglutide, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Anaheim, California
    • +3 more
    Jan 18, 2021

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tucson, Arizona
    • +102 more
    Jan 14, 2021

    Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Insulin degludec
    • Insulin glargine
    • Chandler, Arizona
    • +66 more
    Dec 16, 2020

    Diabetes, Type 2 Trial in San Antonio (vildagliptin + metformin)

    Completed
    • Diabetes Mellitus, Type 2
    • vildagliptin + metformin
    • San Antonio, Texas
      Diabetes and Glandular Disease Research Associates
    Dec 11, 2020

    Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Pell City, Alabama
    • +175 more
    Dec 11, 2020